Skip to main content

Advertisement

Table 1 Demographic and clinical data for the study population

From: Two-dimensional speckle-tracking echocardiography for evaluation of dilative ascending aorta biomechanics

Parameter Controls Diameter of ascending aorta p
Group 1 (≤45 mm) Group 2 (>45 mm) Controls vs. group 1 Controls vs. group 2 Group 1 vs. group 2
Age (years) 58.2 ± 7.1 52.9 ± 13.8 60.1 ± 12.2 NS NS NS
Sex (F/M) (%) 43.3/56.7 18.8/81.2 25.0/75.0 NS NS NS
Body surface area (m2) 1.91 ± 0.2 2.01 ± 0.2 2.0 ± 0.2 NS NS NS
Arterial hypertension (%) 65.2 60.0 89.3 NS 0.02 0.02
Blood pressure (mmHg)
 Systolic 134.6 ± 13.7 138.8 ± 17.7 145.8 ± 23.5 NS 0.01 NS
 Diastolic 84.1 ± 9.6 73.4 ± 13.0 78.8 ± 11.8 0.003 0.03 NS
Antihypertensive Rx (%)
 β-Blockers 25.5 85.7 77.8 <0.05 0.001 NS
 ACE-I 22.0 64.3 55.6 <0.05 0.002 NS
 ARB 17.6 7.7 18.5 NS NS NS
Smokers (%) 28.8 0 7.4 <0.05 0.02 NS
Aortic valve pathology (%)
 Aortic valve insufficiency 0 50.0 53.8 <0.001 <0.001 NS
 Stenosis 0 6.2 15.4 NS 0.002 NS
 Bicuspid 0 62.5 30.4 0.001 0.001 0.04
  1. ACE-I angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers, NS not significant, Rx treatment, Values are mean (SD) unless otherwise indicated